Another great move and step forward towards the commercialisation of this product.
As Bedger says the Aussie market and fund managers are tone deaf to the biotech sector.
The needle will move with increasing sales and US FDA approvals - we will get there and the rewards will be significant.
- Forums
- ASX - By Stock
- Ann: Leading US-based nerve surgeons appointed to advisory board
Another great move and step forward towards the...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
42.5¢ |
Change
-0.005(1.16%) |
Mkt cap ! $89.07M |
Open | High | Low | Value | Volume |
43.0¢ | 43.0¢ | 42.0¢ | $90.9K | 214.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12850 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 24056 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8850 | 0.420 |
2 | 11426 | 0.415 |
6 | 120649 | 0.410 |
2 | 26293 | 0.405 |
8 | 83050 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 24056 | 2 |
0.435 | 10000 | 1 |
0.440 | 1400 | 1 |
0.445 | 99431 | 2 |
0.450 | 27875 | 1 |
Last trade - 15.54pm 27/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |